MedPath

Early Recanalization After Intravenous Thrombolysis With Tenecteplase Versus Alteplase in Distal Vessel Occlusion Strokes

Recruiting
Conditions
Acute Distal Vessel Occlusion Stroke
Interventions
Registration Number
NCT05635786
Lead Sponsor
Centre Hospitalier Sud Francilien
Brief Summary

The purpose of this monocentric retrospective study is to compare, in patients with acute distal vessel occlusion stroke, the early rates of successful recanalization in patients treated with Alteplase (ALT) versus Tenecteplase (TNK), based on a retrospective analysis of magnetic resonance imaging (MRI) performed early after IVT.

Detailed Description

Early rates of successful recanalization (SR) of distal vessel occlusions (DVO) following intravenous thrombolysis (IVT) between alteplase (ALT) and tenecteplase (TNK) are poorly known.

From March 2016 to February 2020, consecutive stroke patients hospitalized in the stroke unit of the Sud-Francilien Hospital with DVO identified on baseline MRI and suitable for IVT but not for mechanical thrombectomy will be included. In our stroke unit, patients were treated with ALT, 0.9 mg/kg from March 2016 to February 2018 and then with TNK, 0.25 mg/kg from March 2018 to February 2020. MRI was controlled 1-2 hours within IVT (MRI-2). Early recanalization was assessed on an adapted Arterial Occlusion Lesion (AOL) scale, SR being defined as AOL 2/3 scores on MRI-2. The rate reduction of thrombus length (TL) when thrombus persisted, the IVT response threshold of TL and the infarct size evolution were also assessed. In the present study, the investigators sought to compare early rates of SR between the two lytics, based on a retrospective analysis of magnetic resonance imaging (MRI) performed early after IVT.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
481
Inclusion Criteria
  • Age≥ 18 years.

  • Acute ischemic stroke (visible on DWI, but not visible on FLAIR) on initial MRI associated with distal arterial occlusion as defined below:

    • A distal occlusion of the M2 segment of the middle cerebral artery (MCA)
    • Occlusion (regardless of location) of a non-dominant M2 branch of the MCA
    • Occlusion of the M3 segment of the MCA.
    • Occlusion of the A2 or A3 segment of the anterior cerebral artery (ACA)
    • Occlusion of the P2 or P3 branch of the posterior cerebral artery (PCA).
    • A proximal M2-MCA or proximal P1-PCA occlusion may also be included if not eligible for mechanical thrombectomy, especially if the initial NIHSS score is low (<5).
    • Distal arterial occlusion is identified by MRI either on the TOF (Time of Flight)-ARM sequence and/or on the presence of a thrombus (Susceptibility Vessel sign, SVS) on the SWAN sequence,
  • IVT by ALT or TNK within 4H30 after onset of symptoms,

  • Early brain MRI performed 1 to 2 hours after IVT (MRI n°2),

  • Good quality MRI (absence of motion artifact interfering with interpretation) with availability of DWI, FLAIR, TOF-MRA and SWAN sequences.

Read More
Exclusion Criteria
  • Patients informed of the study who objected to the collection of their data.
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Alteplase (ALT)Alteplase (0.9mg/kg)Patients with distal vessel occlusion stroke treated with alteplase (from March 2016 to February 2018)
Tenecteplase (TNK)Tenecteplase (0.25mg/kg)Patients with distal vessel occlusion stroke treated with tenecteplase (from March 2018 to February 2020)
Primary Outcome Measures
NameTimeMethod
Early successful recanalization rateBetween 1 and 2 hours after IVT

Early successful recanalization rate defined by an Arterial Occlusive Lesion (AOL) scale grade 2 or 3 on MRI-2 performed between 1 and 2 hours after IVT.

Secondary Outcome Measures
NameTimeMethod
Evolution of cerebral infarct volumeBetween 1 and 2 hours after IVT

Volume of the ischemic lesion will be assessed on the diffusion-weighted imaging (DWI) sequence using an automated software (Olea software).

This evolution of cerebral infarct volume will be calculated as follows : DWI MRI volume n°2 - initial DWI MRI volume.

Rates of early post-thrombolysis intracerebral hemorrhageBetween 1 and 2 hours after IVT

Rates of early post-thrombolysis intracerebral hemorrhage on MRI-2 (performed at 1 to 2h after IVT) according to the Heidelberg classification (Kummer et al, Stroke 2015)

Thrombus length changeBetween 1 and 2 hours after IVT

Thrombus length (TL) was approximated by measuring the susceptibility vessel sign (SVS) on the susceptibility weight angiography (SWAN) sequence.

TL were measured in the 3 spatial planes, the higher value being retained. When thrombus persisted on MRI-2, TL reduction was assessed as follows : (MRI-1 length - MRI-2 length)/MRI-1 length X 100.

Very early clinical modificationBetween 1 and 2 hours after IVT

Very early neurological modification was assessed as follows : baseline NIHSS -NIHSS at H1.

Very early clinical improvement (VENI) was defined as baseline NIHSS -NIHSS at H1. ≥4, or NIHSS H1=0.

Early complete recanalization rateBetween 1 and 2 hours after IVT

Early complete successful recanalization rate defined by an Arterial Occlusive Lesion (AOL) scale grade 3 on MRI-2 performed between 1 and 2 hours after IVT.

Trial Locations

Locations (1)

Centre Hospitalier Sud Francilien

🇫🇷

Corbeil-Essonnes, France

© Copyright 2025. All Rights Reserved by MedPath